HUP0203161A3 - Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use - Google Patents

Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use

Info

Publication number
HUP0203161A3
HUP0203161A3 HU0203161A HUP0203161A HUP0203161A3 HU P0203161 A3 HUP0203161 A3 HU P0203161A3 HU 0203161 A HU0203161 A HU 0203161A HU P0203161 A HUP0203161 A HU P0203161A HU P0203161 A3 HUP0203161 A3 HU P0203161A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
benzamidine derivatives
benzamidine
Prior art date
Application number
HU0203161A
Other languages
English (en)
Original Assignee
Sankyo Company Ltd Chuo Ku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Ltd Chuo Ku filed Critical Sankyo Company Ltd Chuo Ku
Publication of HUP0203161A2 publication Critical patent/HUP0203161A2/hu
Publication of HUP0203161A3 publication Critical patent/HUP0203161A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)
HU0203161A 1999-10-28 2000-10-25 Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use HUP0203161A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30719299 1999-10-28
PCT/JP2000/007469 WO2001030756A1 (fr) 1999-10-28 2000-10-25 Derives de benzamidine

Publications (2)

Publication Number Publication Date
HUP0203161A2 HUP0203161A2 (hu) 2002-12-28
HUP0203161A3 true HUP0203161A3 (en) 2003-12-29

Family

ID=17966162

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203161A HUP0203161A3 (en) 1999-10-28 2000-10-25 Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use

Country Status (26)

Country Link
US (3) US6555556B1 (hu)
EP (1) EP1245564B1 (hu)
KR (1) KR100642953B1 (hu)
CN (2) CN1572882A (hu)
AT (1) ATE322479T1 (hu)
AU (1) AU776193B2 (hu)
BR (1) BR0015120A (hu)
CA (1) CA2389156C (hu)
CY (1) CY1106116T1 (hu)
CZ (1) CZ20021432A3 (hu)
DE (1) DE60027204T2 (hu)
DK (1) DK1245564T3 (hu)
ES (1) ES2261248T3 (hu)
HK (1) HK1047431B (hu)
HU (1) HUP0203161A3 (hu)
IL (2) IL149306A0 (hu)
MX (1) MXPA02004218A (hu)
NO (1) NO323147B1 (hu)
NZ (1) NZ518581A (hu)
PL (1) PL354619A1 (hu)
PT (1) PT1245564E (hu)
RU (1) RU2222529C2 (hu)
TR (1) TR200201654T2 (hu)
TW (1) TWI226886B (hu)
WO (1) WO2001030756A1 (hu)
ZA (1) ZA200203278B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2222529C2 (ru) * 1999-10-28 2004-01-27 Санкио Компани, Лимитед Производные бензамидина
MXPA03009097A (es) * 2001-04-05 2004-02-12 Sankyo Co Derivados de benzamidina.
WO2002089803A1 (en) * 2001-05-07 2002-11-14 Sankyo Company, Limited Composition for iontophoresis
MXPA04009007A (es) * 2002-03-15 2005-07-01 Kissei Pharmaceutical Nuevos cristales de derivado de 5-hidroxicarbamimidoil-2-hidroxi-bencenosulfonamida.
DK1701722T3 (da) * 2004-11-23 2010-01-11 Dong Wha Pharm Co Ltd N-Hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidin-2-methansulfonsyresalt
CN103159620A (zh) * 2013-03-28 2013-06-19 广西师范大学 一种2-羟基间苯二甲酸的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
US5731324A (en) * 1993-07-22 1998-03-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
ATE233240T1 (de) 1994-12-02 2003-03-15 Yamanouchi Pharma Co Ltd Neues amidinonaphthylderivat oder dessen salz
CN1273128C (zh) * 1996-01-02 2006-09-06 阿温蒂斯药物公司 取代的n－[(氨基亚氨基甲基或氨基甲基)苯基]丙基酰胺
CZ86199A3 (cs) * 1996-09-12 1999-08-11 Schering Aktiengesellschaft Benzamidinové deriváty substituované cyklickou aminokyselinou a cyklické hydrokyselinové deriváty, farmaceutický prostředek obsahující tyto látky a jejich použití jako protisrážecích činidel
TW542822B (en) * 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
AU3857300A (en) * 1999-02-11 2000-08-29 Cor Therapeutics, Inc. Inhibitors of factor xa
US6350761B1 (en) * 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
RU2222529C2 (ru) * 1999-10-28 2004-01-27 Санкио Компани, Лимитед Производные бензамидина

Also Published As

Publication number Publication date
EP1245564B1 (en) 2006-04-05
DE60027204D1 (en) 2006-05-18
EP1245564A4 (en) 2003-03-05
HUP0203161A2 (hu) 2002-12-28
ZA200203278B (en) 2003-08-26
PL354619A1 (en) 2004-02-09
US6555556B1 (en) 2003-04-29
AU776193B2 (en) 2004-09-02
CN1413189A (zh) 2003-04-23
CZ20021432A3 (cs) 2002-10-16
CY1106116T1 (el) 2011-06-08
AU7957400A (en) 2001-05-08
DE60027204T2 (de) 2006-11-23
RU2222529C2 (ru) 2004-01-27
MXPA02004218A (es) 2002-10-17
CA2389156C (en) 2009-05-12
KR100642953B1 (ko) 2006-11-10
ATE322479T1 (de) 2006-04-15
KR20020092347A (ko) 2002-12-11
NO20021990D0 (no) 2002-04-26
HK1047431A1 (en) 2003-02-21
DK1245564T3 (da) 2006-08-14
US20040010009A1 (en) 2004-01-15
PT1245564E (pt) 2006-06-30
EP1245564A1 (en) 2002-10-02
HK1047431B (zh) 2006-07-14
ES2261248T3 (es) 2006-11-16
NO20021990L (no) 2002-06-25
WO2001030756A1 (fr) 2001-05-03
TR200201654T2 (tr) 2002-12-23
CA2389156A1 (en) 2001-05-03
CN1293052C (zh) 2007-01-03
TWI226886B (en) 2005-01-21
NO323147B1 (no) 2007-01-08
NZ518581A (en) 2004-11-26
BR0015120A (pt) 2002-06-25
CN1572882A (zh) 2005-02-02
IL149306A0 (en) 2002-11-10
US20040248981A1 (en) 2004-12-09
IL149306A (en) 2007-07-04

Similar Documents

Publication Publication Date Title
HUP0300618A3 (en) Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0204245A3 (en) Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0105114A3 (en) Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
HUP0203316A3 (en) Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0200396A3 (en) Gluckokinase activators, process for their preparation, pharmaceutical compositions containing them and their use
HUP0204515A3 (en) 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203294A3 (en) Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
HUP0300616A3 (en) Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203052A3 (en) Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0204410A3 (en) Pyrimidine-4-one derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203136A3 (en) Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201516A3 (en) 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201753A3 (en) Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203140A3 (en) Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203184A3 (en) Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
HUP0202731A3 (en) O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201315A3 (en) 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0303045A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL147248A0 (en) Naphthyridine derivatives, process for their preparation, their use and pharmaceutical compositions comprising them